AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 92 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | +100.0% | 3,200 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 3,200 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 3,200 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 3,200 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 3,200 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -71.4% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -36.4% | 3,200 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $11,000 | -15.4% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,000 | +550.0% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $5,710,000 | 4.85% |
| Cypress Capital Management LLC (WY) | 321,725 | $708,000 | 0.74% |
| Noven Financial Group, Inc. | 103,964 | $229,000 | 0.12% |
| Transform Wealth, LLC | 205,481 | $452,000 | 0.08% |
| Cutter & CO Brokerage, Inc. | 50,000 | $110,000 | 0.04% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 44,500 | $98,000 | 0.04% |
| GHP Investment Advisors, Inc. | 100,000 | $220,000 | 0.03% |
| BRIGHTON JONES LLC | 85,555 | $188,000 | 0.02% |
| Valeo Financial Advisors, LLC | 330,000 | $155,000 | 0.02% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 27,348 | $60,000 | 0.02% |